Agilent Technologies Inc vs Sirius XM Holdings Inc — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Sirius XM Holdings Inc trades at $28.55 (market cap $9.70B). The key difference: Agilent Technologies Inc is far larger — about 4.3× Sirius XM Holdings Inc's market cap, and Sirius XM Holdings Inc pays the higher dividend (3.75%). Which is the better fit depends on your goals.
| A | SIRI | |
|---|---|---|
Market Cap | $42.00B | $9.70B |
Sector | Health | Media |
52-Week High | $157.20 | $32.59 |
52-Week Low | $110.24 | $19.92 |
Enterprise Value | $43.55B | $18.98B |
Dividend Yield | 0.69% | 3.75% |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
Sirius XM Holdings (SIRI) trades at $29.91, showing minimal daily movement (+0.1%) with a bullish technical signal from moving averages. The company demonstrates stable fundamentals with a P/E of 12.01 and net income margin of 10.23%, though Q2 2026 earnings missed expectations. Recent news highlights dividend declarations and institutional activity, while cash flow trends show improvement with projected positive net cash flow for 2026.
The outlook remains cautiously optimistic with analyst consensus favoring Buy ratings (58%) and a $33.17 price target suggesting 11% upside. Key risks include competitive pressures in audio streaming and execution challenges, but strong cash flow generation and reduced leverage support shareholder returns through dividends and potential buybacks.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →